New insight into RASopathy-associated lymphatic defects

February 8, 2013

The RAS pathway is a cellular signaling pathway that regulates growth and development in humans. RASopathies are a group of diseases characterized by defects in RAS signaling.

Many patients with RASopathies present with defects in the lymphatic system, which removes excess fluid from tissues, absorbs fats from the digestive system, and transports immune cells.

To determine how alterations in the RAS pathway affect development of the lymphatic system, researchers at Yale University generated that expressed mutations associated with a RASopathy known as .

In this issue of the , Michael Simon and colleagues report that excess RAS pathway activation triggers increased activity of a protein known as ERK.

Mice with RASopathy-associated mutations exhibited lymphatic defects similar to those seen in humans, but the defects could be reversed by treatment with an ERK inhibitor.

These findings demonstrate that excessive ERK activation underlies lymphatic defects in RASopathies and suggest that ERK inhibition could be a useful therapeutic strategy.

Explore further: Mutations common to cancer and developmental disorder examined in a novel disease model

More information: Endothelial ERK signaling controls lymphatic fate specification, Journal of Clinical Investigation, doi:10.1172/JCI63034

Related Stories

Lack of specific gene plays role in autism

February 9, 2009

It is estimated that three to six out of every 1,000 children in the United States have autism - and the number of diagnosed cases is rising. Autism is one of a group of series developmental problems called autism spectrum ...

Natural compound shows promise against Huntington's disease

November 15, 2010

Fisetin, a naturally occurring compound found in strawberries and other fruits and vegetables, slows the onset of motor problems and delays death in three models of Huntington's disease, according to researchers at the Salk ...

Combination therapies for drug-resistant cancers

October 10, 2011

Some cancers can be effectively treated with drugs inhibiting proteins known as receptor tyrosine kinases, but not those cancers caused by mutations in the KRAS gene. A team of researchers led by Jeffrey Engelman, at Massachusetts ...

Recommended for you

Zika virus may persist in the vagina days after infection

August 25, 2016

The Zika virus reproduces in the vaginal tissue of pregnant mice several days after infection, according to a study by Yale researchers. From the genitals, the virus spreads and infects the fetal brain, impairing fetal development. ...

In sub-Saharan Africa, cancer can be an infectious disease

August 26, 2016

In 1963, Irish surgeon Denis Parson Burkitt airmailed samples of an unusual jaw tumor found in Ugandan children to his colleague, Anthony Epstein, at Middlesex Hospital in London. Epstein, an expert in chicken viruses and ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.